CurrentCardio
Get Weekly

CurrentCardio coverage · page 2 of 2

Nature Medicine

Briefs 41–80 of 80 CurrentCardio has covered from this journal, newest publication first

Latest from Nature Medicine

All coverage, newest first

  1. Nat Med

    Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

    Randomised controlled trialHeart failure

  2. Nat Med

    Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial

    Randomised controlled trialArrhythmias & EP

  3. Nat Med

    Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial

    Randomised controlled trialArrhythmias & EP

  4. Nat Med

    Preeclampsia risk prediction from prenatal cell-free DNA screening

    Diagnostic or prognostic studyCardio-oncology & other

  5. Nat Med

    Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography

    Diagnostic or prognostic studyArrhythmias & EP

  6. Nat Med

    Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial

    Randomised controlled trialCardiometabolic & kidney

  7. Nat Med

    Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial

    Randomised controlled trialHeart failure

  8. Nat Med

    Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

    Secondary analysisHeart failure

  9. Nat Med

    Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

    Randomised controlled trialCardiometabolic & kidney

  10. Nat Med

    Echocardiographic screening for heart failure and optimization of the care pathway for individuals with pacemakers: a randomized controlled trial

    Randomised controlled trialHeart failure

  11. Nat Med

    Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial

    Randomised controlled trialCardio-oncology & other

  12. Nat Med

    Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

    Meta-analysisCardiometabolic & kidney

  13. Nat Med

    Digital consults in heart failure care: a randomized controlled trial

    Randomised controlled trialHeart failure

  14. Nat Med

    Unidirectional association of clonal hematopoiesis with atherosclerosis development

    Cohort studyPrevention & lipids

  15. Nat Med

    Role of anticoagulation therapy in modifying stroke risk associated with new-onset atrial fibrillation after non-cardiac surgery

    Cohort studyArrhythmias & EP

  16. Nat Med

    Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

    Meta-analysisCoronary & ACS

  17. Nat Med

    The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

    Randomised controlled trialHeart failure

  18. Nat Med

    An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    Diagnostic or prognostic studyHeart failure

  19. Nat Med

    Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

    Cohort studyArrhythmias & EP

  20. Nat Med

    Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk

    Cohort study

  21. Nat Med

    Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk

    Cohort studyArrhythmias & EP

  22. Nat Med

    IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

    Randomised controlled trialCardiometabolic & kidney

  23. Nat Med

    Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

    Secondary analysisCardiometabolic & kidney

  24. Nat Med

    Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes

    Mechanistic studyCoronary & ACS

  25. Nat Med

    Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial

    Randomised controlled trialArrhythmias & EP

  26. Nat Med

    Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure

    Cohort studyCardiometabolic & kidney

  27. Nat Med

    Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

    Secondary analysisCardiometabolic & kidney

  28. Nat Med

    Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging

    Diagnostic or prognostic study

  29. Nat Med

    Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial

    Randomised controlled trialPrevention & lipids

  30. Nat Med

    A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials

    Secondary analysis

  31. Nat Med

    Vision–language foundation model for echocardiogram interpretation

    Diagnostic or prognostic study

  32. Nat Med

    Development and validation of a new algorithm for improved cardiovascular risk prediction

    Diagnostic or prognostic studyPrevention & lipids

  33. Nat Med

    Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease

    Meta-analysisPrevention & lipids

  34. Nat Med

    Sex-specific genetic architecture of blood pressure

    Research articleHypertension

  35. Nat Med

    Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial

    Randomised controlled trialArrhythmias & EP

  36. Nat Med

    Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial

    Randomised controlled trialHeart failure

  37. Nat Med

    Cell-free DNA methylome analysis for early preeclampsia prediction

    Diagnostic or prognostic studyCardio-oncology & other

  38. Nat Med

    Genomic profiling informs diagnoses and treatment in vascular anomalies

    Cohort study

  39. Nat Med

    Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations

    Diagnostic or prognostic study

  40. Nat Med

    Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial

    Randomised controlled trial

All 80 Briefs in ExploreShowing Briefs 41–80 of 80, newest first